Oztekin Sermin, Hepaguşlar Hasan, Kilercik Hakan, Kar Aysun Afife, Boyaci Figen, Elar Zahide
Department of Anaesthesiology, Dokuz Eylül University Hospital, Izmir, Turkey.
Paediatr Anaesth. 2004 Aug;14(8):636-41. doi: 10.1111/j.1460-9592.2004.01273.x.
In this prospective double-blind study, intubation conditions were compared at 90 s following two different low doses of rocuronium during remifentanil and propofol anesthesia in children undergoing ambulatory procedures.
Forty-four children (ASA I-II, aged 3-12 years) undergoing day case ENT surgery were premedicated with midazolam 0.5 mg x kg(-1). Following atropine 10 microg x kg(-1), remifentanil infusion 0.5 microg x kg(-1) x min(-1) was started. After 60 s, anesthesia was induced with propofol 2.5 mg x kg(-1). Immediately after a bolus dose of propofol, the children received rocuronium doses of 0.15 mg x kg(-1) (group I, n = 22) or 0.3 mg x kg(-1) (group II, n = 22) in a randomized manner, after which an infusion of propofol 6 mg x kg(-1) h(-1) was added to the infusion of remifentanil 0.5 microg x kg(-1) min(-1) for maintenance of anesthesia. Intubating conditions were evaluated 90 s after rocuronium administration applying the Copenhagen Scoring System which included components of laryngoscopy, vocal cord movement and reaction to intubation. Hemodynamic values were recorded at predetermined time intervals.
Excellent, good and poor intubation conditions were 18.2, 40.9 and 40.9% in group I and 40.9, 54.5 and 4.5% in group II. Clinically acceptable intubating conditions (excellent and good) were significantly higher in group II (95.5%) than in group I (59.1%) (P = 0.004). Mean values of heart rate and blood pressure did not differ significantly between groups. No children required any intervention for hemodynamic instability and/or muscle rigidity.
The results suggest that 0.3 mg x kg(-1) of rocuronium may be a better low dose than 0.15 mg x kg(-1) of rocuronium for clinically acceptable intubating conditions in pediatric ambulatory surgery during remifentanil-propofol-based anesthesia at the doses used in the study.
在这项前瞻性双盲研究中,比较了在接受门诊手术的儿童瑞芬太尼和丙泊酚麻醉期间,两种不同低剂量罗库溴铵给药90秒后的插管条件。
44例接受日间耳鼻喉手术的儿童(ASA I-II级,年龄3-12岁),术前用咪达唑仑0.5mg·kg⁻¹进行预处理。给予阿托品10μg·kg⁻¹后,开始输注瑞芬太尼0.5μg·kg⁻¹·min⁻¹。60秒后,用丙泊酚2.5mg·kg⁻¹诱导麻醉。在静脉推注丙泊酚后,儿童以随机方式接受0.15mg·kg⁻¹的罗库溴铵(I组,n = 22)或0.3mg·kg⁻¹的罗库溴铵(II组,n = 22),之后在输注瑞芬太尼0.5μg·kg⁻¹·min⁻¹的基础上,加用丙泊酚6mg·kg⁻¹·h⁻¹进行麻醉维持。在罗库溴铵给药90秒后,应用哥本哈根评分系统评估插管条件,该评分系统包括喉镜检查、声带运动和对插管的反应等方面。在预定的时间间隔记录血流动力学值。
I组插管条件优、良、差的比例分别为18.2%、40.9%和40.9%,II组分别为40.9%、54.5%和4.5%。II组临床可接受的插管条件(优和良)显著高于I组(95.5%比59.1%)(P = 0.004)。两组间心率和血压的平均值无显著差异。没有儿童因血流动力学不稳定和/或肌肉强直需要任何干预。
结果表明,在本研究使用的剂量下,对于基于瑞芬太尼-丙泊酚麻醉的小儿门诊手术,临床可接受的插管条件而言,0.3mg·kg⁻¹的罗库溴铵可能比0.15mg·kg⁻¹的罗库溴铵是更好的低剂量。